Mediplantex National Pharmaceutical JSC (HNX:MED)

Vietnam flag Vietnam · Delayed Price · Currency is VND
22,600
-200 (-0.88%)
At close: Oct 6, 2025
-0.88%
Market Cap280.47B
Revenue (ttm)355.39B
Net Income (ttm)12.10B
Shares Out12.41M
EPS (ttm)975.46
PE Ratio23.17
Forward PEn/a
Dividend900.00 (3.98%)
Ex-Dividend DateJul 16, 2025
Volume6,650
Average Volume24,923
Open22,700
Previous Close22,800
Day's Range22,600 - 22,700
52-Week Range22,600 - 28,600
Beta0.09
RSI41.46
Earnings DateOct 23, 2025

About HNX:MED

Mediplantex National Pharmaceutical Joint Stock Company produces and trades in pharmaceutical products in Vietnam and internationally. The company offers pharmaceutical products in various categories, including drugs from herbals; analgesics, corticosteroid, and anti-inflammatory drugs; antibiotics; cerebral circulation, heart, and lung drugs; anti-malarial, demostasis, gout, diabetes, allergies, and osteoarthritis drugs; acid amin, vitamins, and minerals; and other products. It also provides pharmaceutical chemicals and medicinal herbs; and ex... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 328
Stock Exchange Hanoi Stock Exchange
Ticker Symbol MED
Full Company Profile

Financial Performance

In 2024, HNX:MED's revenue was 443.14 billion, an increase of 10.03% compared to the previous year's 402.74 billion. Earnings were 15.25 billion, an increase of 29.83%.

Financial Statements

News

There is no news available yet.